-
Lake Street Capital Initiates Pareteum, Turnaround Positive
Monday, September 24, 2018 - 4:11pm | 349Communications provider Pareteum Corp. (NYSE: TEUM) exhibits well-executed turnaround, underappreciated growth and tremendous share upside. The Analyst Lake Street Capital Markets analyst Eric Martinuzzi initiated coverage on Pareteum with a Buy rating and a $5 price target. The Thesis In...
-
Lake Street Feels Confident In Himax Growth Opportunities
Thursday, September 28, 2017 - 10:29am | 538Following investor meetings Lake Street Capital Markets hosted with Himax Technologies, Inc. (ADR) (NASDAQ: HIMX) management, the firm said it came away increasingly confident in the growth opportunities the company has in the core driver business and non-driver segment, particularly in the 3D...
-
Power Solutions Sees Downgrades After SEC Investigation, Trading Halt
Monday, February 6, 2017 - 1:16pm | 426Power Solutions International Inc (NASDAQ: PSIX) was downgraded by three analysts Monday after the company’s shares lost more than half their value Friday and trading was temporarily halted. Power Solutions is under investigation by the Securities and Exchange Commission, according to a...
-
Nano Dimension Shares Initiated With Buy Rating By Lake Street
Tuesday, September 27, 2016 - 10:22am | 330Lake Street Capital Markets initiated coverage of Nano Dimension Ltd - ADR (NASDAQ: NNDM) with a Buy rating and a price target of $12. Analyst Eric Martinuzzi pointed to Nano Dimension's "revolutionary" multilayer circuit board printer, the DragonFly 2020, as the reason for their positive rating....
-
Invuity Products Popular With Surgeons, Lake Street Initiates Buy Rating
Monday, September 19, 2016 - 11:51am | 322Lake Street Capital Markets initiated Invuity Inc. (NASDAQ: IVTY) at Buy with a $18 price target, as the firm believes the company's shares deserve a premium valuation relative to its peer group. Illuminating Prospects The brokerage highlighted the company's proprietary photonics technology as...
-
Lake Street Capital Likes Felxion's Lead Drug Candidate, Prescribes A Buy Rating
Tuesday, September 6, 2016 - 10:37am | 322Flexion Therapeutics Inc (NASDAQ: FLXN) is expected to submit NDA for its lead drug candidate, Zilretta, in Q4 this year. Zilretta seems “well positioned to emerge as a breakthrough, best-in-class therapy,” Lake Street Capital Markets’ Bruce D. Jackson said in a report. He...
-
FDA Approval Of Heron Therapeutics' Lead Product Has Lake Street Recommending A Buy
Tuesday, September 6, 2016 - 10:25am | 272The FDA has approved Heron Therapeutics Inc’s (NASDAQ: HRTX) lead product Sustol and now the company appears poised to benefit from “existing multi-billion dollar market opportunities,” Lake Street Capital Markets’ Bruce D. Jackson said in a report. He assigned a Buy...
-
Weakness in Aratana Shares An 'Excellent' Entry Point
Friday, July 15, 2016 - 10:10am | 238Aratana Therapeutics Inc (NASDAQ: PETX) seems to be firing on all cylinders and the recent weakness in shares represents an attractive buying opportunity, Lake Street Capital Markets’ Carl Byrnes said in a report. He reiterated a Buy rating on the company, with a price target of $15....
-
Lake Streets Starts Xactly At Buy, Says Stock Could Worth More Than $20 If Salesforce Buys Company
Wednesday, May 18, 2016 - 3:06pm | 503Lake Street Capital Markets has started Xactly Corp (NYSE: XTLY) with a Buy rating and $12 price target, saying that last year's sales investments would bear fruit this year. Moreover, the brokerage said the stock could be worth more than $20 if salesforce.com, inc. (NYSE: CRM) buys the company....
-
UPDATE: Lake Street Initiates Coverage On EXACT Sciences
Monday, January 5, 2015 - 12:36pm | 241Lake Street Capital Markets initiated coverage on EXACT Sciences Corporation (NASDAQ: EXAS) with a Buy rating and $33.00 price target. Analyst Bruce D. Jackson noted that since “Cologuard has obtained a $492.72 per test reimbursement rate from Medicare, we think there is upside potential...
-
Lake Street Initiates Coverage On Planar Systems
Tuesday, November 25, 2014 - 2:55pm | 196Lake Street Capital Markets initiated coverage on Planar Systems, Inc. (NASDAQ: PLNR) Tuesday with a Buy rating and $8.50 price target. Analyst Jaeson Schmidt believed “Planar Systems has turned the corner, where the Digital Signage (D.S.) segment continues to ramp (up 36 percent y/y in...
-
Himax Technologies, Inc. Falls 2%, Lake Street Raises Price Target
Wednesday, October 8, 2014 - 11:43am | 147Lake Street Capital Markets reiterated a Buy rating and raised the price target from $8.50 to $12 for Himax Technologies, Inc. (NASDAQ: HIMX) in report issued Wednesday. Analyst Jaeson Schmidt noted that recent checks with other suppliers "give us increased confidence that Himax’s...
-
UPDATE: Lake Street Capital Initiates Coverage On Carbonite Inc
Thursday, October 2, 2014 - 3:54pm | 197Lake Street Capital Markets initiated coverage of Carbonite Inc (NASDAQ: CARB) with a Buy rating and $16 price target. Analyst Eric Martinuzzi issued a report in which he expressed that Carbonite represents a “hidden growth story.” According to the report, investors may still...
-
UPDATE: Lake Street Capital Downgrades Westport Innovations Inc.
Wednesday, October 1, 2014 - 9:26am | 174Westport Innovations Inc. (USA) (NASDAQ: WPRT) had its rating lowered to Hold by Lake Street Capital Markets on Wednesday and its price target lowered from $45 to $20. Analyst Robert D. Brown wrote that his firm was "disappointed in the reduced outlook and delay in new program launches....
-
Chart Industries, Inc. Surges Higher Following Positive Comments
Tuesday, September 23, 2014 - 3:44pm | 141Shares of Chart Industries, Inc. (NASDAQ: GTLS) continue to move sharply higher Tuesday afternoon following positive comments from Lake Street Capital Markets. Analysts at the firm declared “Chart Industries is one one the few remaining stand-alone public companies in the shale energy and...